Publication Cover
Radiation Effects and Defects in Solids
Incorporating Plasma Science and Plasma Technology
Volume 179, 2024 - Issue 1-2: Editor's Special
19
Views
1
CrossRef citations to date
0
Altmetric
Articles

Development of a radiochemical test procedure for the separation of aerosol-borne allergens

ORCID Icon, , & ORCID Icon
Pages 76-85 | Received 17 Dec 2023, Accepted 07 Feb 2024, Published online: 24 Apr 2024
 

Abstract

An innovative radiochemical method has been developed to determine the filtration efficiency of HEPA filters for biological nanoparticles. The setup based on EN 1822, for flat sheet media, is up to 40 times more sensitive for a single particle than methods based on particle counting, even for low particle concentrations. To achieve such a high sensitivity the radioactive tracer technique is utilised using a solution of bovine serum albumin (BSA) labelled with radioactive iodine (131I). With the aid of an aerosol generator, this solution is nebulised into nanoparticles of a defined size, which are then passed to the test filter via a compressed air flow. On the raw and clean gas side of the test filter, the 131I is measured with two NaI(Tl) detectors. By balancing the measurement data with each other, the filter efficiency can be determined. Initially, the setup has been validated with current particle counting methods, according to EN 1822, to ensure its functionality. Subsequently, the first experiments with radiolabelled nanoparticles gave promising results, as will be shown below. Further experiments also yielded information about filter clogging and its influence on the filter efficiency.

Acknowledgements

Special thanks to Klawego GmbH & Co. KG for providing the filter materials. I would also like to thank Dr. E. Gottschall, Dr. K. Gottschall, Dr. D. Krupp, M. Kuss and Dr. P. Pfeuffer, whose input and support of the research project has contributed significantly to its success.

Disclosure statement

Dr. L. Lens reports financial support was provided by Karl-Völker-Stiftung. Dr. L. Lens reports equipment, drugs, or supplies was provided by Klawego GmbH & Co. KG. Dr. L. Lens reports a relationship with Karl-Völker-Stiftung that includes funding grants.

Additional information

Funding

This document is the result of a research project funded by the Karl-Völker-Stiftung.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.